VISD GP Share Price Swiss Exchange
Equities
OXVMG
FR0011067669
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
26/03 | Visiomed: share price rises on 'record' 2023 results | CF |
13/02 | Visiomed: 38% increase in annual sales | CF |
Sales 2021 | 71.79L 78.15L 65Cr | Sales 2022 | 1.44Cr 1.57Cr 131.31Cr | Capitalization | 9.85Cr 11Cr 895.86Cr |
---|---|---|---|---|---|
Net income 2021 | -40L -43.54L -36Cr | Net income 2022 | -50L -54.43L -45Cr | EV / Sales 2021 | 1.38 x |
Net cash position 2021 | 16.15L 17.58L 15Cr | Net Debt 2022 | 32.56L 35.45L 30Cr | EV / Sales 2022 | 7.05 x |
P/E ratio 2021 |
-1.33
x | P/E ratio 2022 |
-22.7
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.94% |
Managers | Title | Age | Since |
---|---|---|---|
Clement Pacaud
CEO | Chief Executive Officer | 34 | 22/01 |
Investor Relations Contact | - | - | |
Thomas Picquette
SEC | Corporate Secretary | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Thomas Picquette
SEC | Corporate Secretary | - | 01/22/01 |
Anne Gaignard
BRD | Director/Board Member | - | 01/22/01 |
1st Jan change | Capi. | |
---|---|---|
-4.98% | 18TCr | |
+2.84% | 11TCr | |
-2.68% | 6.79TCr | |
+4.53% | 5.01TCr | |
+8.00% | 4.43TCr | |
+9.65% | 4.04TCr | |
+25.30% | 3.2TCr | |
-0.17% | 2.58TCr | |
+21.57% | 2.53TCr |
- Stock Market
- Equities
- ALVMG Stock
- OXVMG Stock